Literature DB >> 23209160

Synaptic targets of Δ9-tetrahydrocannabinol in the central nervous system.

Alexander F Hoffman1, Carl R Lupica.   

Abstract

The availability of potent synthetic agonists for cannabinoid receptors has facilitated our understanding of cannabinoid actions on synaptic transmission in the central nervous system. Moreover, the ability of these compounds to inhibit neurotransmitter release at many central synapses is thought to underlie most of the behavioral effects of cannabinoid agonists. However, despite the widespread use and misuse of marijuana, and recognition of its potential adverse psychological effects in humans, comparatively few studies have examined the actions of its primary psychoactive constituent, Δ(9)-tetrahydrocannabinol (THC), at well-defined synaptic pathways. Here we examine the recent literature describing the effects of acute and repeated THC exposure on synaptic function in several brain regions and explore the importance of these neurobiological actions of THC in drug addiction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23209160      PMCID: PMC3721267          DOI: 10.1101/cshperspect.a012237

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  106 in total

1.  Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens.

Authors:  D Robbe; G Alonso; F Duchamp; J Bockaert; O J Manzoni
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

2.  Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.

Authors:  N Hájos; I Katona; S S Naiem; K MacKie; C Ledent; I Mody; T F Freund
Journal:  Eur J Neurosci       Date:  2000-09       Impact factor: 3.386

Review 3.  CB2: a cannabinoid receptor with an identity crisis.

Authors:  Brady K Atwood; Ken Mackie
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

4.  Inactivation of dorsolateral striatum enhances sensitivity to changes in the action-outcome contingency in instrumental conditioning.

Authors:  Henry H Yin; Barbara J Knowlton; Bernard W Balleine
Journal:  Behav Brain Res       Date:  2005-09-08       Impact factor: 3.332

Review 5.  Endocannabinoid-mediated control of synaptic transmission.

Authors:  Masanobu Kano; Takako Ohno-Shosaku; Yuki Hashimotodani; Motokazu Uchigashima; Masahiko Watanabe
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

Review 6.  Functions and modulation of neuronal SK channels.

Authors:  E S Louise Faber
Journal:  Cell Biochem Biophys       Date:  2009-08-05       Impact factor: 2.194

Review 7.  Pharmacology of cannabinoid CB1 and CB2 receptors.

Authors:  R G Pertwee
Journal:  Pharmacol Ther       Date:  1997       Impact factor: 12.310

8.  Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia.

Authors:  Wei Xiong; Kejun Cheng; Tanxing Cui; Grzegorz Godlewski; Kenner C Rice; Yan Xu; Li Zhang
Journal:  Nat Chem Biol       Date:  2011-04-03       Impact factor: 15.040

Review 9.  Cannabis: pharmacology and toxicology in animals and humans.

Authors:  I B Adams; B R Martin
Journal:  Addiction       Date:  1996-11       Impact factor: 6.526

10.  Postsynaptic endocannabinoid release is critical to long-term depression in the striatum.

Authors:  G L Gerdeman; J Ronesi; D M Lovinger
Journal:  Nat Neurosci       Date:  2002-05       Impact factor: 24.884

View more
  20 in total

Review 1.  Building smart cannabis policy from the science up.

Authors:  Susan R B Weiss; Katia D Howlett; Ruben D Baler
Journal:  Int J Drug Policy       Date:  2017-02-08

Review 2.  Cannabinoid abuse and addiction: Clinical and preclinical findings.

Authors:  L V Panlilio; S R Goldberg; Z Justinova
Journal:  Clin Pharmacol Ther       Date:  2015-05-02       Impact factor: 6.875

3.  CB1-receptor-mediated inhibitory LTD triggers presynaptic remodeling via protein synthesis and ubiquitination.

Authors:  Hannah R Monday; Mathieu Bourdenx; Bryen A Jordan; Pablo E Castillo
Journal:  Elife       Date:  2020-09-09       Impact factor: 8.140

Review 4.  Different Paths to Core Pathology: The Equifinal Model of the Schizophrenia Syndrome.

Authors:  Isobel W Green; Jill R Glausier
Journal:  Schizophr Bull       Date:  2015-09-20       Impact factor: 9.306

5.  Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol.

Authors:  Arnau Busquets-Garcia; Maria Gomis-González; Victòria Salgado-Mendialdúa; Lorena Galera-López; Emma Puighermanal; Elena Martín-García; Rafael Maldonado; Andrés Ozaita
Journal:  Neuropsychopharmacology       Date:  2017-08-17       Impact factor: 7.853

Review 6.  The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis.

Authors:  M D Scofield; J A Heinsbroek; C D Gipson; Y M Kupchik; S Spencer; A C W Smith; D Roberts-Wolfe; P W Kalivas
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

7.  Cocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental Area.

Authors:  Huikun Wang; Tyler Treadway; Daniel P Covey; Joseph F Cheer; Carl R Lupica
Journal:  Cell Rep       Date:  2015-09-10       Impact factor: 9.423

8.  Effects of drugs of abuse on channelrhodopsin-2 function.

Authors:  Dominic A Gioia; Minfu Xu; Wesley N Wayman; John J Woodward
Journal:  Neuropharmacology       Date:  2018-03-23       Impact factor: 5.250

9.  Cannabinoids orchestrate cross-talk between cancer cells and endothelial cells in colorectal cancer.

Authors:  Cong-Kai Luo; Pei-Hsuan Chou; Shang-Kok Ng; Wen-Yen Lin; Tzu-Tang Wei
Journal:  Cancer Gene Ther       Date:  2021-05-18       Impact factor: 5.987

Review 10.  Repetitive transcranial magnetic stimulation as a potential treatment approach for cannabis use disorder.

Authors:  Tonisha Kearney-Ramos; Margaret Haney
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2021-03-04       Impact factor: 5.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.